New
Enabling Safe and Effective Reduction of Tricuspid Regurgitation (TR)
Patients with tricuspid regurgitation (TR) are rarely surgically treated1, are medically managed, and often experience debilitating symptoms. While the prevalence of TR and the associated mortality rates for severe TR are high2,3, limited treatment options exist.
The Edwards PASCAL transcatheter valve repair system adds to TMTT's portfolio of TR treatment options and is designed to treat both mitral and tricuspid regurgitation, improving patient symptoms and quality of life using the same device.
An innovative system designed to make leaflet repair a reality for patients with
tricuspid regurgitation
Effectively bridges the coaptation gap while optimising leaflet capture
- Central spacer fills the gap
- Independent grasping
Designed to reduce stress on fragile leaflets
- Broad, contoured paddles
- Atraumatic clasps with a single row of retention elements
Approach your procedure with confidence
- Implant elongation facilitates safe repositioning within the subvalvular apparatus
- Independent catheters allow for precise navigation
Procedure Animation
Watch the PASCAL repair system procedural animation
TMTT Portfolio
Learn more about Edwards' transcatheter mitral
and tricuspid portfolio
References
- Fender EA, Zack CJ, Nishimura RA. Isolated Tricuspid Regurgitation: Outcomes and Therapeutic Interventions. Heart 2018;104:798–806.
- Topilsky Y et al. Burden of Tricuspid Regurgitation in Patients Diagnosed in the Community Setting. JACC Cardiovasc Imaging 2018 Aug 6. Epub 2018 Aug 6
- Nath J, Foster E, Heidenreich PA. Impact of tricuspid regurgitation on long-term survival. J Am Coll Cardiol. 2004;43:405-409.
- Fam NP et al. Compassionate Use of the PASCAL Transcatheter Valve Repair System for Severe Tricuspid Regurgitation: A Multicenter, Observational, First-in-Human Experience. J Am Coll Cardiol. 2019;12(24).
Content relating to Edwards Lifesciences devices is intended for healthcare professionals. Click OK to confirm you are a healthcare professional and proceed, or click Decline to view non-device related content.